ANI Pharmaceuticals has struck a $163.5 million deal to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities. ANI’s board has approved and the acquisition is expected to close in the second half of 2021.   “Strengthening our well-established generics business with enhanced development capabilities and increased focus on niche opportunities is a key pillar of ANI’s growth strategy,” said Nikhil Lalwa...